These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6642709)
1. Synthesis of [1-14C]1,2-cyclohexanedione bis(4-diethylenoxythiosemicarbazone) and preliminary biodistribution studies of this potential antitumor agent. Morgan HK; Varughese A; Williams L Int J Appl Radiat Isot; 1983 Nov; 34(11):1501-4. PubMed ID: 6642709 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of dimethyl tin 4-cyclohexyl thiosemicarbazone as a novel antitumor agent. Sen A; Chaudhuri TK Exp Oncol; 2009 Mar; 31(1):22-6. PubMed ID: 19300412 [TBL] [Abstract][Full Text] [Related]
9. [Studies on the absorption, excretion and distribution of aclacinomycin A: absorption, excretion and distribution of 14C- or 3H-aclacinomycin A in mice, rats and rabbits (author's transl)]. Iguchi H; Seryu Y; Kiyosaki T; Hori S; Tone H; Oki T Jpn J Antibiot; 1980 Feb; 33(2):169-78. PubMed ID: 6929359 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and metabolism of a new antitumor semisynthetic ether phospholipid, 14C-labeled plasmanyl-(N-acyl)ethanolamine, in mice bearing sarcoma Mc11. Kára J; Zimakova NI; Serebryakova EA; Dĕdková V; Zolotaryov AE J Cancer Res Clin Oncol; 1994; 120(11):662-7. PubMed ID: 7962042 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines. Easmon J; Pürstinger G; Heinisch G; Roth T; Fiebig HH; Holzer W; Jäger W; Jenny M; Hofmann J J Med Chem; 2001 Jun; 44(13):2164-71. PubMed ID: 11405653 [TBL] [Abstract][Full Text] [Related]
15. Potential antitumor agents. IV. 4-substituted 1-formylisoquinoline thiosemicarbazones. Agrawal KC; Cushley RJ; McMurray WJ; Sartorelli AC J Med Chem; 1970 May; 13(3):431-4. PubMed ID: 5466487 [No Abstract] [Full Text] [Related]
16. Alpha-(N)-formylheteroaromatic thiosemicarbazones. Inhibition of tumor-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activity. French FA; Blanz EJ; Shaddix SC; Brockman RW J Med Chem; 1974 Feb; 17(2):172-81. PubMed ID: 4809253 [No Abstract] [Full Text] [Related]
17. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system. Iigo M; Kuretani K; Hoshi A Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of thiosemicarbazones. Hu WX; Zhou W; Xia CN; Wen X Bioorg Med Chem Lett; 2006 Apr; 16(8):2213-8. PubMed ID: 16458509 [TBL] [Abstract][Full Text] [Related]
19. Potential antitumor agents. I. A series of 5-substituted 1-formylisoquinoline thiosemicarbazones. Agrawal KC; Booth BA; Sartorelli AC J Med Chem; 1968 Jul; 11(4):700-3. PubMed ID: 5671227 [No Abstract] [Full Text] [Related]
20. Synthesis of 5,6-dihydro-8(7H)-quinolinone thiosemicarbazones as potential antitumor agents. Lemke TL; Shek TW; Cates LA; Smith LK J Med Chem; 1977 Oct; 20(10):1351-4. PubMed ID: 333114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]